Document Type
Article
Publication Date
3-30-2021
Abstract
Neoadjuvant therapy is integral to the treatment of early-stage breast cancer. Goals of treatment include surgical downstaging of the tumor, rendering inoperable tumors resectable, and de-escalating axillary surgery in those with clinically positive nodes. Additionally, response to treatment provides important prognostic information regarding risk of recurrence and guides future adjuvant treatment. Although chemotherapy serves as the backbone of neoadjuvant treatment, an increased understanding of the tumor's clinical course as well as its molecular and genetic make-up aids in individualizing treatment and developing novel agents. This review summarizes current clinical approaches and the future direction to the management of breast cancer patients in the neoadjuvant setting.
Recommended Citation
Hyder, Tara; Bhattacharya, Saveri; Gade, Kristine; Nasrazadani, Azadeh; and Brufsky, Adam M, "Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer." (2021). Department of Medical Oncology Faculty Papers. Paper 139.
https://jdc.jefferson.edu/medoncfp/139
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 3.0 License
PubMed ID
33833568
Language
English
Comments
This article is the author's final published version in Breast Cancer: Targets and Therapy, Volume 13, March 2021, Pages 199-211.
The published version is available at https://doi.org/10.2147/BCTT.S273058
Copyright © 2021 Hyder et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).